Depomed Inc (DEPO.OQ)
26 May 2017
* Depomed - revised each of charters of audit committee, compensation committee, nominating and corporate governance committee
* Depomed announces first quarter 2017 financial results and strategic initiatives aimed at driving sustainable long-term growth and shareholder value
* Depomed announces prepayment of $100 million of secured debt facility
BRIEF-Depomed- Cooperation agreement with Starboard Value LP includes standstill commitments by Starboard
* Depomed- cooperation agreement with Starboard Value LP includes standstill commitments by Starboard
U.S. Democratic Senator Claire McCaskill sought on Tuesday details from the nation's top opioid drugmakers on their sales and marketing practices, as lawmakers step up efforts to tackle the country's deadly opioid crisis.
Depomed Inc reached a deal with activist investor Starboard Value LP to name a new chief executive officer and two other directors to its board.
March 28 Drugmaker Depomed Inc, which has been facing pressure from activist investor Starboard Value LP, named a new chief executive officer and said it would add three new directors to its board.
* Depomed announces cooperation agreement with Starboard Value Lp including CEO and board changes
* Depomed reports fourth quarter and full year 2016 financial results
|Takeda Pharmaceutical Co Ltd (4502.T)||¥5,791||--|
|Shionogi & Co Ltd (4507.T)||¥6,043||--|
|Ranbaxy Laboratories Limited (RANB.NS)||Rs859.80||--|
|Pfizer Inc. (PFE.N)||$32.14||-0.02|
|Johnson & Johnson (JNJ.N)||$126.92||-0.61|
|Merck & Co., Inc. (MRK.N)||$64.92||-0.12|
|GlaxoSmithKline plc (GSK.L)||1,643.50||+25.50|
|Bristol-Myers Squibb Co (BMY.N)||$53.97||-0.42|
|Bristol-Myers Squibb Co (BMYMP.PK)||$940.00||--|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||10,150.00||+20.00|